

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | desmosome organization (GO:0002934) | 5.69514531 |
| 2 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 5.65187164 |
| 3 | diol metabolic process (GO:0034311) | 5.21867700 |
| 4 | negative regulation of cell killing (GO:0031342) | 5.19013402 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.19013402 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 4.95737708 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.95737708 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.95737708 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.95737708 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 4.95737708 |
| 11 | positive regulation by symbiont of host defense response (GO:0052509) | 4.95737708 |
| 12 | receptor recycling (GO:0001881) | 4.84953420 |
| 13 | detection of bacterium (GO:0016045) | 4.80538500 |
| 14 | germinal center formation (GO:0002467) | 4.66232424 |
| 15 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 4.51925397 |
| 16 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 4.35386673 |
| 17 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.33856530 |
| 18 | neutrophil activation involved in immune response (GO:0002283) | 4.23790372 |
| 19 | macrophage activation involved in immune response (GO:0002281) | 4.20374345 |
| 20 | negative regulation of glycoprotein metabolic process (GO:1903019) | 4.08749134 |
| 21 | detection of external biotic stimulus (GO:0098581) | 3.99520166 |
| 22 | sarcomere organization (GO:0045214) | 3.98654513 |
| 23 | sulfate transmembrane transport (GO:1902358) | 3.98241627 |
| 24 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.86468475 |
| 25 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.80006112 |
| 26 | neutrophil activation (GO:0042119) | 3.63996025 |
| 27 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.57072610 |
| 28 | response to peptidoglycan (GO:0032494) | 3.53008078 |
| 29 | positive regulation of B cell differentiation (GO:0045579) | 3.49149888 |
| 30 | detection of molecule of bacterial origin (GO:0032490) | 3.48071253 |
| 31 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.41662899 |
| 32 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.37115128 |
| 33 | response to interleukin-15 (GO:0070672) | 3.36199601 |
| 34 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.36114146 |
| 35 | detection of biotic stimulus (GO:0009595) | 3.33701365 |
| 36 | respiratory burst (GO:0045730) | 3.33495603 |
| 37 | cardiac myofibril assembly (GO:0055003) | 3.31240038 |
| 38 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 3.31160655 |
| 39 | creatine metabolic process (GO:0006600) | 3.28477908 |
| 40 | positive thymic T cell selection (GO:0045059) | 3.26567407 |
| 41 | regulation of mast cell degranulation (GO:0043304) | 3.25141021 |
| 42 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.24870488 |
| 43 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.24870488 |
| 44 | regulation of ARF GTPase activity (GO:0032312) | 3.22740506 |
| 45 | myofibril assembly (GO:0030239) | 3.21942049 |
| 46 | import into cell (GO:0098657) | 3.20189706 |
| 47 | granulocyte activation (GO:0036230) | 3.19354518 |
| 48 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.17612582 |
| 49 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.17199683 |
| 50 | cellular response to epinephrine stimulus (GO:0071872) | 3.16948162 |
| 51 | B cell receptor signaling pathway (GO:0050853) | 3.16494451 |
| 52 | plasma membrane repair (GO:0001778) | 3.16369206 |
| 53 | surfactant homeostasis (GO:0043129) | 3.15617945 |
| 54 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.14455013 |
| 55 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.14259358 |
| 56 | sulfate transport (GO:0008272) | 3.14162900 |
| 57 | regulation of water loss via skin (GO:0033561) | 3.13876295 |
| 58 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.08883296 |
| 59 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.04287865 |
| 60 | negative regulation of T cell mediated immunity (GO:0002710) | 3.03731712 |
| 61 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.03525512 |
| 62 | cellular extravasation (GO:0045123) | 3.02064240 |
| 63 | establishment of skin barrier (GO:0061436) | 3.01797075 |
| 64 | negative regulation of muscle hypertrophy (GO:0014741) | 3.01456289 |
| 65 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.01398056 |
| 66 | cellular response to interleukin-15 (GO:0071350) | 2.99795517 |
| 67 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.99764501 |
| 68 | response to host immune response (GO:0052572) | 2.99148608 |
| 69 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.99148608 |
| 70 | interferon-gamma secretion (GO:0072643) | 2.97923206 |
| 71 | response to type I interferon (GO:0034340) | 2.95751219 |
| 72 | type I interferon signaling pathway (GO:0060337) | 2.95487348 |
| 73 | cellular response to type I interferon (GO:0071357) | 2.95487348 |
| 74 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.94380649 |
| 75 | leukocyte aggregation (GO:0070486) | 2.94288098 |
| 76 | regulation of leukocyte degranulation (GO:0043300) | 2.93764625 |
| 77 | regulation of Cdc42 GTPase activity (GO:0043088) | 2.91932190 |
| 78 | protein-chromophore linkage (GO:0018298) | 2.89944461 |
| 79 | immunoglobulin mediated immune response (GO:0016064) | 2.88829004 |
| 80 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.87518047 |
| 81 | actin-myosin filament sliding (GO:0033275) | 2.86650307 |
| 82 | muscle filament sliding (GO:0030049) | 2.86650307 |
| 83 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.86065191 |
| 84 | response to host (GO:0075136) | 2.86065191 |
| 85 | response to host defenses (GO:0052200) | 2.86065191 |
| 86 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.85933032 |
| 87 | hepatocyte apoptotic process (GO:0097284) | 2.85180541 |
| 88 | DNA methylation involved in gamete generation (GO:0043046) | 2.84510605 |
| 89 | angiogenesis involved in wound healing (GO:0060055) | 2.84114337 |
| 90 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.83551593 |
| 91 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.82957835 |
| 92 | myeloid cell activation involved in immune response (GO:0002275) | 2.82021877 |
| 93 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.81563891 |
| 94 | negative regulation of interleukin-12 production (GO:0032695) | 2.80258070 |
| 95 | negative regulation of monooxygenase activity (GO:0032769) | 2.80134136 |
| 96 | regulation of sequestering of triglyceride (GO:0010889) | 2.79381755 |
| 97 | regulation of protein glycosylation (GO:0060049) | 2.77189543 |
| 98 | macrophage activation (GO:0042116) | 2.76043323 |
| 99 | regulation of the force of heart contraction (GO:0002026) | 2.76012750 |
| 100 | regulation of interleukin-5 production (GO:0032674) | 2.74235099 |
| 101 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.74083112 |
| 102 | cardiac muscle contraction (GO:0060048) | 2.73351630 |
| 103 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.70668660 |
| 104 | response to muramyl dipeptide (GO:0032495) | 2.69699181 |
| 105 | positive regulation of regulated secretory pathway (GO:1903307) | 2.69626598 |
| 106 | regulation of regulated secretory pathway (GO:1903305) | 2.69448996 |
| 107 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.68910133 |
| 108 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.67923034 |
| 109 | flavonoid metabolic process (GO:0009812) | 2.67064900 |
| 110 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.66447355 |
| 111 | positive regulation of histone deacetylation (GO:0031065) | 2.66356585 |
| 112 | positive regulation of mast cell activation (GO:0033005) | 2.66208678 |
| 113 | regulation of ARF protein signal transduction (GO:0032012) | 2.64619972 |
| 114 | embryonic process involved in female pregnancy (GO:0060136) | 2.63407529 |
| 115 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.63102839 |
| 116 | chemical homeostasis within a tissue (GO:0048875) | 2.62817436 |
| 117 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.62538978 |
| 118 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.62469754 |
| 119 | negative regulation of interleukin-6 production (GO:0032715) | 2.61679170 |
| 120 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.60811640 |
| 121 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.60666210 |
| 122 | pantothenate metabolic process (GO:0015939) | 2.59369963 |
| 123 | regulation of monocyte chemotaxis (GO:0090025) | 2.59228729 |
| 124 | leukocyte degranulation (GO:0043299) | 2.58316795 |
| 125 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.58061863 |
| 126 | lipopolysaccharide metabolic process (GO:0008653) | 2.53037146 |
| 127 | defense response to protozoan (GO:0042832) | 2.52785633 |
| 128 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.52615622 |
| 129 | negative regulation of bone resorption (GO:0045779) | 2.52611365 |
| 130 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.52455631 |
| 131 | peptide catabolic process (GO:0043171) | 2.52189693 |
| 132 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.51497529 |
| 133 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.50698769 |
| 134 | heart contraction (GO:0060047) | 2.50048380 |
| 135 | heart process (GO:0003015) | 2.50048380 |
| 136 | mannose metabolic process (GO:0006013) | 2.49215594 |
| 137 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.49189815 |
| 138 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.48818205 |
| 139 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.48607845 |
| 140 | phospholipid scrambling (GO:0017121) | 2.47723442 |
| 141 | positive regulation of interferon-alpha production (GO:0032727) | 2.47246723 |
| 142 | negative regulation of stress fiber assembly (GO:0051497) | 2.45593622 |
| 143 | 2-oxoglutarate metabolic process (GO:0006103) | 2.45577888 |
| 144 | response to epinephrine (GO:0071871) | 2.45033915 |
| 145 | T-helper 1 type immune response (GO:0042088) | 2.44555719 |
| 146 | cardiolipin metabolic process (GO:0032048) | 2.43625115 |
| 147 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.41486186 |
| 148 | regulation of B cell differentiation (GO:0045577) | 2.40493077 |
| 149 | megakaryocyte development (GO:0035855) | 2.38630197 |
| 150 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.37430974 |
| 151 | tetrapyrrole biosynthetic process (GO:0033014) | 2.37026295 |
| 152 | actin-mediated cell contraction (GO:0070252) | 2.36876306 |
| 153 | regulation of relaxation of muscle (GO:1901077) | 2.36781490 |
| 154 | valine metabolic process (GO:0006573) | 2.36073977 |
| 155 | dendritic cell migration (GO:0036336) | 2.35289342 |
| 156 | regulation of actin filament-based movement (GO:1903115) | 2.35212803 |
| 157 | keratinization (GO:0031424) | 2.33953655 |
| 158 | sphingosine metabolic process (GO:0006670) | 2.32100068 |
| 159 | regulation of gamma-delta T cell activation (GO:0046643) | 2.30848027 |
| 160 | detection of other organism (GO:0098543) | 2.30792523 |
| 161 | muscle tissue morphogenesis (GO:0060415) | 2.30614225 |
| 162 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.30540455 |
| 163 | actomyosin structure organization (GO:0031032) | 2.30266653 |
| 164 | fatty acid beta-oxidation (GO:0006635) | 2.29874077 |
| 165 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.29520155 |
| 166 | regulation of interferon-alpha production (GO:0032647) | 2.28665095 |
| 167 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.27580880 |
| 168 | thymic T cell selection (GO:0045061) | 2.27104267 |
| 169 | regulation of T cell tolerance induction (GO:0002664) | 2.26812361 |
| 170 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.26554480 |
| 171 | dendritic cell chemotaxis (GO:0002407) | 2.26523929 |
| 172 | growth hormone receptor signaling pathway (GO:0060396) | 2.26117450 |
| 173 | positive regulation of cholesterol efflux (GO:0010875) | 2.25699950 |
| 174 | sphingoid metabolic process (GO:0046519) | 2.25340397 |
| 175 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.24479508 |
| 176 | regulation of cholesterol storage (GO:0010885) | 2.24254590 |
| 177 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.24095655 |
| 178 | lymph vessel development (GO:0001945) | 2.22851774 |
| 179 | positive regulation of p38MAPK cascade (GO:1900745) | 2.22782207 |
| 180 | regulation of p38MAPK cascade (GO:1900744) | 2.21926990 |
| 181 | epithelial cell-cell adhesion (GO:0090136) | 2.20548196 |
| 182 | glomerular visceral epithelial cell development (GO:0072015) | 2.19413102 |
| 183 | carnitine shuttle (GO:0006853) | 2.19019836 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.48295483 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.75404066 |
| 3 | GATA1_22025678_ChIP-Seq_K562_Human | 4.64874892 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.37877535 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.99247248 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.78841821 |
| 7 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.72823346 |
| 8 | GATA1_19941826_ChIP-Seq_K562_Human | 2.29188025 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.19715356 |
| 10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.18105176 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.16206687 |
| 12 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.13363855 |
| 13 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.12128836 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.06061367 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 2.03770025 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.97203839 |
| 17 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.93905258 |
| 18 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.93607178 |
| 19 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.92158000 |
| 20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.90649670 |
| 21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.90553775 |
| 22 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.90530883 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.89222503 |
| 24 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.86174832 |
| 25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.85750475 |
| 26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.84537452 |
| 27 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.83099091 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.82730346 |
| 29 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.79028364 |
| 30 | GATA2_19941826_ChIP-Seq_K562_Human | 1.78568534 |
| 31 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.76250736 |
| 32 | P68_20966046_ChIP-Seq_HELA_Human | 1.73752093 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 1.72961505 |
| 34 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.69430742 |
| 35 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.68388076 |
| 36 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.67306068 |
| 37 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.66393830 |
| 38 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.66075021 |
| 39 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.62162520 |
| 40 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.61733326 |
| 41 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.61087248 |
| 42 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.56636180 |
| 43 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.56293212 |
| 44 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.54973671 |
| 45 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.54389782 |
| 46 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.54389782 |
| 47 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.53347478 |
| 48 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.53291394 |
| 49 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.52096449 |
| 50 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.50726869 |
| 51 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.50041318 |
| 52 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.49855838 |
| 53 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.49584808 |
| 54 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.49481043 |
| 55 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.46908045 |
| 56 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.45804931 |
| 57 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44988594 |
| 58 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.44622583 |
| 59 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.42764696 |
| 60 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.42246093 |
| 61 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.41373600 |
| 62 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.40644568 |
| 63 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.40133047 |
| 64 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.39908464 |
| 65 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39547159 |
| 66 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.39453376 |
| 67 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.38703794 |
| 68 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38107128 |
| 69 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.37946351 |
| 70 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37500288 |
| 71 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37101389 |
| 72 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.34167323 |
| 73 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.34030533 |
| 74 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32858087 |
| 75 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31075460 |
| 76 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.31050142 |
| 77 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.29961258 |
| 78 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.27059666 |
| 79 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.26277393 |
| 80 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25847013 |
| 81 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25767461 |
| 82 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.25692040 |
| 83 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25226591 |
| 84 | KDM2B_26808549_Chip-Seq_K562_Human | 1.25019463 |
| 85 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.24668145 |
| 86 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.23770905 |
| 87 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23756710 |
| 88 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.23518641 |
| 89 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.23113835 |
| 90 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.23091247 |
| 91 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.22974276 |
| 92 | UTX_26944678_Chip-Seq_JUKART_Human | 1.22731552 |
| 93 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.20981425 |
| 94 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.20647049 |
| 95 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.20340997 |
| 96 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.19280865 |
| 97 | SA1_27219007_Chip-Seq_Bcells_Human | 1.18866920 |
| 98 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.18865030 |
| 99 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.18771616 |
| 100 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.18060066 |
| 101 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.17426668 |
| 102 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.16835190 |
| 103 | MYB_26560356_Chip-Seq_TH2_Human | 1.16773590 |
| 104 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.16701214 |
| 105 | SPI1_23127762_ChIP-Seq_K562_Human | 1.16460657 |
| 106 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.15520284 |
| 107 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.15450595 |
| 108 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.14548587 |
| 109 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.14003891 |
| 110 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.13818825 |
| 111 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13323573 |
| 112 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.12969798 |
| 113 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12156132 |
| 114 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.11367592 |
| 115 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11245150 |
| 116 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11175089 |
| 117 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.11077654 |
| 118 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.10658806 |
| 119 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.10105525 |
| 120 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.09476843 |
| 121 | MAF_26560356_Chip-Seq_TH2_Human | 1.08722216 |
| 122 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.07669588 |
| 123 | P300_27268052_Chip-Seq_Bcells_Human | 1.07545389 |
| 124 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.06718063 |
| 125 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.06098782 |
| 126 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.06035883 |
| 127 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.05404191 |
| 128 | ATF3_27146783_Chip-Seq_COLON_Human | 1.05032403 |
| 129 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.03862050 |
| 130 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.03246083 |
| 131 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.02785481 |
| 132 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.02785481 |
| 133 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.01691078 |
| 134 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01334802 |
| 135 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.00249788 |
| 136 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.99354987 |
| 137 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98658240 |
| 138 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.97824766 |
| 139 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.97653497 |
| 140 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.96932459 |
| 141 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.96462518 |
| 142 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.96265303 |
| 143 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.96055064 |
| 144 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.95478927 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002653_abnormal_ependyma_morphology | 3.39906669 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 3.36100805 |
| 3 | MP0002796_impaired_skin_barrier | 3.28286715 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 3.11909657 |
| 5 | MP0003136_yellow_coat_color | 2.95708291 |
| 6 | MP0004084_abnormal_cardiac_muscle | 2.90427194 |
| 7 | MP0003300_gastrointestinal_ulcer | 2.58389474 |
| 8 | MP0004036_abnormal_muscle_relaxation | 2.32503120 |
| 9 | MP0005377_hearing/vestibular/ear_phenot | 2.29977193 |
| 10 | MP0003878_abnormal_ear_physiology | 2.29977193 |
| 11 | MP0003656_abnormal_erythrocyte_physiolo | 2.26585649 |
| 12 | MP0002132_abnormal_respiratory_system | 2.26541450 |
| 13 | MP0003646_muscle_fatigue | 2.26113865 |
| 14 | MP0004264_abnormal_extraembryonic_tissu | 2.23510189 |
| 15 | MP0003866_abnormal_defecation | 2.21079915 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.17768052 |
| 17 | MP0004510_myositis | 2.10253704 |
| 18 | MP0004130_abnormal_muscle_cell | 2.08290032 |
| 19 | MP0004947_skin_inflammation | 2.05458945 |
| 20 | MP0010155_abnormal_intestine_physiology | 2.04158809 |
| 21 | MP0005501_abnormal_skin_physiology | 2.03342881 |
| 22 | MP0001835_abnormal_antigen_presentation | 2.01489628 |
| 23 | MP0005275_abnormal_skin_tensile | 1.97360393 |
| 24 | MP0003183_abnormal_peptide_metabolism | 1.96700133 |
| 25 | MP0000751_myopathy | 1.94376602 |
| 26 | MP0000343_altered_response_to | 1.93533897 |
| 27 | MP0003879_abnormal_hair_cell | 1.93422028 |
| 28 | MP0004215_abnormal_myocardial_fiber | 1.90950849 |
| 29 | MP0003828_pulmonary_edema | 1.90788664 |
| 30 | MP0005171_absent_coat_pigmentation | 1.86296819 |
| 31 | MP0005058_abnormal_lysosome_morphology | 1.82437496 |
| 32 | MP0002277_abnormal_respiratory_mucosa | 1.79757534 |
| 33 | MP0004147_increased_porphyrin_level | 1.68116805 |
| 34 | MP0005451_abnormal_body_composition | 1.67182456 |
| 35 | MP0005330_cardiomyopathy | 1.67176109 |
| 36 | MP0004185_abnormal_adipocyte_glucose | 1.66907839 |
| 37 | MP0003172_abnormal_lysosome_physiology | 1.66720133 |
| 38 | MP0008260_abnormal_autophagy | 1.65720380 |
| 39 | MP0002972_abnormal_cardiac_muscle | 1.65024908 |
| 40 | MP0004484_altered_response_of | 1.64530622 |
| 41 | MP0002166_altered_tumor_susceptibility | 1.63090931 |
| 42 | MP0008775_abnormal_heart_ventricle | 1.55542718 |
| 43 | MP0003303_peritoneal_inflammation | 1.55226422 |
| 44 | MP0004087_abnormal_muscle_fiber | 1.54990074 |
| 45 | MP0005085_abnormal_gallbladder_physiolo | 1.52260558 |
| 46 | MP0003566_abnormal_cell_adhesion | 1.51436866 |
| 47 | MP0005075_abnormal_melanosome_morpholog | 1.50862978 |
| 48 | MP0000749_muscle_degeneration | 1.48670049 |
| 49 | MP0002148_abnormal_hypersensitivity_rea | 1.48474738 |
| 50 | MP0001790_abnormal_immune_system | 1.48130299 |
| 51 | MP0005387_immune_system_phenotype | 1.48130299 |
| 52 | MP0003453_abnormal_keratinocyte_physiol | 1.46382346 |
| 53 | MP0003436_decreased_susceptibility_to | 1.46213149 |
| 54 | MP0003724_increased_susceptibility_to | 1.43417332 |
| 55 | MP0005409_darkened_coat_color | 1.41679797 |
| 56 | MP0010630_abnormal_cardiac_muscle | 1.41174847 |
| 57 | MP0000465_gastrointestinal_hemorrhage | 1.40389951 |
| 58 | MP0002419_abnormal_innate_immunity | 1.39279670 |
| 59 | MP0005000_abnormal_immune_tolerance | 1.38363095 |
| 60 | MP0002396_abnormal_hematopoietic_system | 1.38173915 |
| 61 | MP0001544_abnormal_cardiovascular_syste | 1.37947324 |
| 62 | MP0005385_cardiovascular_system_phenoty | 1.37947324 |
| 63 | MP0004043_abnormal_pH_regulation | 1.36843662 |
| 64 | MP0005025_abnormal_response_to | 1.35456930 |
| 65 | MP0006082_CNS_inflammation | 1.34151676 |
| 66 | MP0000716_abnormal_immune_system | 1.33521834 |
| 67 | MP0008961_abnormal_basal_metabolism | 1.33294476 |
| 68 | MP0002009_preneoplasia | 1.32873901 |
| 69 | MP0002006_tumorigenesis | 1.32349047 |
| 70 | MP0001216_abnormal_epidermal_layer | 1.32045939 |
| 71 | MP0009840_abnormal_foam_cell | 1.31330923 |
| 72 | MP0005464_abnormal_platelet_physiology | 1.31227419 |
| 73 | MP0005670_abnormal_white_adipose | 1.30617988 |
| 74 | MP0000750_abnormal_muscle_regeneration | 1.29728019 |
| 75 | MP0003890_abnormal_embryonic-extraembry | 1.28821770 |
| 76 | MP0004381_abnormal_hair_follicle | 1.28775707 |
| 77 | MP0005365_abnormal_bile_salt | 1.28405155 |
| 78 | MP0005666_abnormal_adipose_tissue | 1.28308312 |
| 79 | MP0001853_heart_inflammation | 1.25502550 |
| 80 | MP0005620_abnormal_muscle_contractility | 1.22197151 |
| 81 | MP0001800_abnormal_humoral_immune | 1.21308258 |
| 82 | MP0000678_abnormal_parathyroid_gland | 1.20733497 |
| 83 | MP0000685_abnormal_immune_system | 1.19998924 |
| 84 | MP0005076_abnormal_cell_differentiation | 1.19655792 |
| 85 | MP0002452_abnormal_antigen_presenting | 1.17231034 |
| 86 | MP0002098_abnormal_vibrissa_morphology | 1.17030847 |
| 87 | MP0002722_abnormal_immune_system | 1.14754153 |
| 88 | MP0003941_abnormal_skin_development | 1.14521880 |
| 89 | MP0002723_abnormal_immune_serum | 1.13399853 |
| 90 | MP0009333_abnormal_splenocyte_physiolog | 1.13057086 |
| 91 | MP0006138_congestive_heart_failure | 1.12188591 |
| 92 | MP0003950_abnormal_plasma_membrane | 1.11012229 |
| 93 | MP0002420_abnormal_adaptive_immunity | 1.10925186 |
| 94 | MP0005360_urolithiasis | 1.09911720 |
| 95 | MP0002877_abnormal_melanocyte_morpholog | 1.09637705 |
| 96 | MP0001819_abnormal_immune_cell | 1.08324676 |
| 97 | MP0005671_abnormal_response_to | 1.08126470 |
| 98 | MP0000470_abnormal_stomach_morphology | 1.07627188 |
| 99 | MP0003045_fibrosis | 1.07406352 |
| 100 | MP0001663_abnormal_digestive_system | 1.07272060 |
| 101 | MP0005375_adipose_tissue_phenotype | 1.04796763 |
| 102 | MP0002106_abnormal_muscle_physiology | 1.04711150 |
| 103 | MP0009785_altered_susceptibility_to | 1.04213621 |
| 104 | MP0002971_abnormal_brown_adipose | 1.03640498 |
| 105 | MP0002060_abnormal_skin_morphology | 1.03550443 |
| 106 | MP0010771_integument_phenotype | 1.03060616 |
| 107 | MP0009764_decreased_sensitivity_to | 1.03027563 |
| 108 | MP0010678_abnormal_skin_adnexa | 1.02825980 |
| 109 | MP0000703_abnormal_thymus_morphology | 1.02699555 |
| 110 | MP0002429_abnormal_blood_cell | 1.02038986 |
| 111 | MP0003705_abnormal_hypodermis_morpholog | 1.00472601 |
| 112 | MP0000490_abnormal_crypts_of | 1.00400330 |
| 113 | MP0001845_abnormal_inflammatory_respons | 0.98135356 |
| 114 | MP0005319_abnormal_enzyme/_coenzyme | 0.97607810 |
| 115 | MP0000689_abnormal_spleen_morphology | 0.97268774 |
| 116 | MP0000858_altered_metastatic_potential | 0.96894178 |
| 117 | MP0003448_altered_tumor_morphology | 0.96676069 |
| 118 | MP0008004_abnormal_stomach_pH | 0.96320176 |
| 119 | MP0009931_abnormal_skin_appearance | 0.95157738 |
| 120 | MP0005310_abnormal_salivary_gland | 0.94009397 |
| 121 | MP0002138_abnormal_hepatobiliary_system | 0.93657984 |
| 122 | MP0005165_increased_susceptibility_to | 0.93160374 |
| 123 | MP0001533_abnormal_skeleton_physiology | 0.92088952 |
| 124 | MP0003763_abnormal_thymus_physiology | 0.91791233 |
| 125 | MP0005083_abnormal_biliary_tract | 0.90720687 |
| 126 | MP0002405_respiratory_system_inflammati | 0.90467293 |
| 127 | MP0009643_abnormal_urine_homeostasis | 0.90292317 |
| 128 | MP0006036_abnormal_mitochondrial_physio | 0.88948098 |
| 129 | MP0001879_abnormal_lymphatic_vessel | 0.88598678 |
| 130 | MP0008469_abnormal_protein_level | 0.88419508 |
| 131 | MP0000377_abnormal_hair_follicle | 0.85101221 |
| 132 | MP0006054_spinal_hemorrhage | 0.84492993 |
| 133 | MP0009278_abnormal_bone_marrow | 0.83996799 |
| 134 | MP0002398_abnormal_bone_marrow | 0.81094368 |
| 135 | MP0001873_stomach_inflammation | 0.80759117 |
| 136 | MP0000747_muscle_weakness | 0.79868841 |
| 137 | MP0000015_abnormal_ear_pigmentation | 0.77866487 |
| 138 | MP0002168_other_aberrant_phenotype | 0.77292988 |
| 139 | MP0010352_gastrointestinal_tract_polyps | 0.76739665 |
| 140 | MP0002933_joint_inflammation | 0.76607503 |
| 141 | MP0001851_eye_inflammation | 0.75015215 |
| 142 | MP0001765_abnormal_ion_homeostasis | 0.73479926 |
| 143 | MP0009115_abnormal_fat_cell | 0.72699021 |
| 144 | MP0005381_digestive/alimentary_phenotyp | 0.71524545 |
| 145 | MP0008874_decreased_physiological_sensi | 0.68661684 |
| 146 | MP0002095_abnormal_skin_pigmentation | 0.68480552 |
| 147 | MP0002075_abnormal_coat/hair_pigmentati | 0.63646657 |
| 148 | MP0000367_abnormal_coat/_hair | 0.62651154 |
| 149 | MP0002998_abnormal_bone_remodeling | 0.61724545 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ventricular tachycardia (HP:0004756) | 5.05260200 |
| 2 | Right ventricular cardiomyopathy (HP:0011663) | 4.92392141 |
| 3 | Amelogenesis imperfecta (HP:0000705) | 4.83705120 |
| 4 | Sudden death (HP:0001699) | 4.62041309 |
| 5 | Increased IgE level (HP:0003212) | 4.44694474 |
| 6 | Hyporeflexia of lower limbs (HP:0002600) | 4.37910881 |
| 7 | Tetraparesis (HP:0002273) | 4.36652134 |
| 8 | Myositis (HP:0100614) | 4.06764531 |
| 9 | Abnormality of macrophages (HP:0004311) | 4.06641464 |
| 10 | Muscle fiber splitting (HP:0003555) | 3.90450048 |
| 11 | Orchitis (HP:0100796) | 3.85802312 |
| 12 | Bilateral sensorineural hearing impairment (HP:0008619) | 3.80851806 |
| 13 | Eczematoid dermatitis (HP:0000976) | 3.70200120 |
| 14 | Polycythemia (HP:0001901) | 3.48464661 |
| 15 | Obstructive lung disease (HP:0006536) | 3.47579549 |
| 16 | Chronic obstructive pulmonary disease (HP:0006510) | 3.47579549 |
| 17 | Testicular atrophy (HP:0000029) | 3.45999380 |
| 18 | Acanthocytosis (HP:0001927) | 3.45043235 |
| 19 | Gastrointestinal infarctions (HP:0005244) | 3.41717219 |
| 20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.36928971 |
| 21 | Recurrent fungal infections (HP:0002841) | 3.36456333 |
| 22 | Calf muscle hypertrophy (HP:0008981) | 3.35269525 |
| 23 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.31932532 |
| 24 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.29922083 |
| 25 | Subaortic stenosis (HP:0001682) | 3.29922083 |
| 26 | Retrobulbar optic neuritis (HP:0100654) | 3.29347677 |
| 27 | Optic neuritis (HP:0100653) | 3.29347677 |
| 28 | Exercise-induced muscle cramps (HP:0003710) | 3.28796364 |
| 29 | Gangrene (HP:0100758) | 3.15435457 |
| 30 | Erythroderma (HP:0001019) | 3.10447525 |
| 31 | Exercise-induced myalgia (HP:0003738) | 3.02831008 |
| 32 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.98378971 |
| 33 | Petechiae (HP:0000967) | 2.95127961 |
| 34 | Recurrent skin infections (HP:0001581) | 2.93068267 |
| 35 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.92939912 |
| 36 | Gastrointestinal inflammation (HP:0004386) | 2.92507919 |
| 37 | Hypochromic anemia (HP:0001931) | 2.90860841 |
| 38 | Meningitis (HP:0001287) | 2.90613405 |
| 39 | Increased connective tissue (HP:0009025) | 2.90063676 |
| 40 | Lipoatrophy (HP:0100578) | 2.89654908 |
| 41 | Atrial fibrillation (HP:0005110) | 2.85613749 |
| 42 | Myoglobinuria (HP:0002913) | 2.84448430 |
| 43 | Gingivitis (HP:0000230) | 2.82773879 |
| 44 | Distal lower limb muscle weakness (HP:0009053) | 2.78525571 |
| 45 | Poikilocytosis (HP:0004447) | 2.78307447 |
| 46 | Recurrent abscess formation (HP:0002722) | 2.77845695 |
| 47 | EMG: myopathic abnormalities (HP:0003458) | 2.77332296 |
| 48 | Sepsis (HP:0100806) | 2.74557812 |
| 49 | Vasculitis (HP:0002633) | 2.72625521 |
| 50 | Severe visual impairment (HP:0001141) | 2.70988558 |
| 51 | Stomatitis (HP:0010280) | 2.70467180 |
| 52 | Panhypogammaglobulinemia (HP:0003139) | 2.68698219 |
| 53 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.66651343 |
| 54 | Keratoconjunctivitis sicca (HP:0001097) | 2.66241101 |
| 55 | Primary atrial arrhythmia (HP:0001692) | 2.63686488 |
| 56 | Mediastinal lymphadenopathy (HP:0100721) | 2.63517890 |
| 57 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.59283534 |
| 58 | Hemoptysis (HP:0002105) | 2.58291263 |
| 59 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.56583589 |
| 60 | Recurrent bacterial skin infections (HP:0005406) | 2.55573189 |
| 61 | Interstitial pulmonary disease (HP:0006530) | 2.55278934 |
| 62 | Axonal loss (HP:0003447) | 2.54064899 |
| 63 | Supraventricular tachycardia (HP:0004755) | 2.53611525 |
| 64 | Pustule (HP:0200039) | 2.52092211 |
| 65 | Supraventricular arrhythmia (HP:0005115) | 2.51454952 |
| 66 | Myocardial infarction (HP:0001658) | 2.51109134 |
| 67 | Rectal prolapse (HP:0002035) | 2.51037278 |
| 68 | Dilated cardiomyopathy (HP:0001644) | 2.50924547 |
| 69 | Cholelithiasis (HP:0001081) | 2.48891621 |
| 70 | Asymmetric septal hypertrophy (HP:0001670) | 2.48262139 |
| 71 | Esophageal varix (HP:0002040) | 2.47794437 |
| 72 | Hypochromic microcytic anemia (HP:0004840) | 2.46261935 |
| 73 | Keratoconjunctivitis (HP:0001096) | 2.45160417 |
| 74 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.40640309 |
| 75 | Recurrent cutaneous fungal infections (HP:0011370) | 2.40640309 |
| 76 | Paralysis (HP:0003470) | 2.38661114 |
| 77 | Parakeratosis (HP:0001036) | 2.37540309 |
| 78 | Autoimmune thrombocytopenia (HP:0001973) | 2.36863983 |
| 79 | Abnormality of the calf musculature (HP:0001430) | 2.36688776 |
| 80 | Palmoplantar keratoderma (HP:0000982) | 2.35495047 |
| 81 | Conjunctival hamartoma (HP:0100780) | 2.34735554 |
| 82 | Ventricular fibrillation (HP:0001663) | 2.33886383 |
| 83 | Hematochezia (HP:0002573) | 2.33880210 |
| 84 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.32085060 |
| 85 | Spontaneous hematomas (HP:0007420) | 2.32006791 |
| 86 | Severe Myopia (HP:0011003) | 2.31342049 |
| 87 | Difficulty running (HP:0009046) | 2.30329909 |
| 88 | Cerebral hemorrhage (HP:0001342) | 2.30137532 |
| 89 | Reticulocytosis (HP:0001923) | 2.30091960 |
| 90 | Flat acetabular roof (HP:0003180) | 2.29574299 |
| 91 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.28624434 |
| 92 | Encephalitis (HP:0002383) | 2.28487820 |
| 93 | Rhabdomyolysis (HP:0003201) | 2.27317747 |
| 94 | Thin bony cortex (HP:0002753) | 2.24692030 |
| 95 | Peritonitis (HP:0002586) | 2.21709875 |
| 96 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.19786259 |
| 97 | Increased cerebral lipofuscin (HP:0011813) | 2.19624245 |
| 98 | Pulmonary embolism (HP:0002204) | 2.18744930 |
| 99 | Abnormal gallbladder morphology (HP:0012437) | 2.18062876 |
| 100 | Hyperactive renin-angiotensin system (HP:0000841) | 2.16903197 |
| 101 | Hemorrhage of the eye (HP:0011885) | 2.16841577 |
| 102 | Erythema (HP:0010783) | 2.15360190 |
| 103 | Urticaria (HP:0001025) | 2.15302319 |
| 104 | Mesangial abnormality (HP:0001966) | 2.14987119 |
| 105 | Syncope (HP:0001279) | 2.12189150 |
| 106 | Hypotrichosis (HP:0001006) | 2.10434852 |
| 107 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.07565633 |
| 108 | Systemic lupus erythematosus (HP:0002725) | 2.07416830 |
| 109 | Ventricular arrhythmia (HP:0004308) | 2.07018634 |
| 110 | Areflexia of lower limbs (HP:0002522) | 2.06919438 |
| 111 | Facial diplegia (HP:0001349) | 2.06553246 |
| 112 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.06362459 |
| 113 | Malnutrition (HP:0004395) | 2.06231080 |
| 114 | Colitis (HP:0002583) | 2.05815667 |
| 115 | Cellulitis (HP:0100658) | 2.05128765 |
| 116 | Granulocytopenia (HP:0001913) | 2.04308026 |
| 117 | Epistaxis (HP:0000421) | 2.02938244 |
| 118 | Palpitations (HP:0001962) | 1.99719256 |
| 119 | J-shaped sella turcica (HP:0002680) | 1.99392526 |
| 120 | Hyperbilirubinemia (HP:0002904) | 1.97613888 |
| 121 | Vacuolated lymphocytes (HP:0001922) | 1.97583281 |
| 122 | Abnormality of the nasal mucosa (HP:0000433) | 1.97059191 |
| 123 | Esophageal neoplasm (HP:0100751) | 1.95768021 |
| 124 | Neoplasm of head and neck (HP:0012288) | 1.95768021 |
| 125 | Abnormality of the fingertips (HP:0001211) | 1.95291791 |
| 126 | Hypergammaglobulinemia (HP:0010702) | 1.95282225 |
| 127 | Chest pain (HP:0100749) | 1.94634690 |
| 128 | Palmoplantar hyperkeratosis (HP:0000972) | 1.94595595 |
| 129 | Anorexia (HP:0002039) | 1.94348011 |
| 130 | Gingival bleeding (HP:0000225) | 1.94222830 |
| 131 | Premature loss of primary teeth (HP:0006323) | 1.93047909 |
| 132 | Woolly hair (HP:0002224) | 1.92241474 |
| 133 | Nephritis (HP:0000123) | 1.92206721 |
| 134 | Recurrent viral infections (HP:0004429) | 1.92083603 |
| 135 | Episodic fever (HP:0001954) | 1.91268011 |
| 136 | Metaphyseal cupping (HP:0003021) | 1.91194161 |
| 137 | Myotonia (HP:0002486) | 1.90657400 |
| 138 | Sudden cardiac death (HP:0001645) | 1.90514044 |
| 139 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.89838938 |
| 140 | Chronic diarrhea (HP:0002028) | 1.89360624 |
| 141 | Impaired platelet aggregation (HP:0003540) | 1.88522817 |
| 142 | Abnormal platelet function (HP:0011869) | 1.88522817 |
| 143 | Decreased circulating renin level (HP:0003351) | 1.88261109 |
| 144 | Seborrheic dermatitis (HP:0001051) | 1.88042290 |
| 145 | Cheilitis (HP:0100825) | 1.87258628 |
| 146 | Dehydration (HP:0001944) | 1.84844276 |
| 147 | T lymphocytopenia (HP:0005403) | 1.84675995 |
| 148 | Bundle branch block (HP:0011710) | 1.84145866 |
| 149 | Verrucae (HP:0200043) | 1.81661770 |
| 150 | Papilloma (HP:0012740) | 1.81661770 |
| 151 | Lymphopenia (HP:0001888) | 1.81117328 |
| 152 | Pili torti (HP:0003777) | 1.80206217 |
| 153 | Emphysema (HP:0002097) | 1.79772921 |
| 154 | Inflammation of the large intestine (HP:0002037) | 1.79039481 |
| 155 | Increased serum ferritin (HP:0003281) | 1.78819799 |
| 156 | Abnormality of nail color (HP:0100643) | 1.78526556 |
| 157 | Distal lower limb amyotrophy (HP:0008944) | 1.78193743 |
| 158 | Leukocytosis (HP:0001974) | 1.78104243 |
| 159 | Microcytic anemia (HP:0001935) | 1.77998464 |
| 160 | Purpura (HP:0000979) | 1.77542770 |
| 161 | Prolonged bleeding time (HP:0003010) | 1.77322094 |
| 162 | Skin ulcer (HP:0200042) | 1.76267798 |
| 163 | Vertebral arch anomaly (HP:0008438) | 1.75430971 |
| 164 | Thickened calvaria (HP:0002684) | 1.75406582 |
| 165 | Deformed sella turcica (HP:0002681) | 1.73676418 |
| 166 | Abnormality of T cells (HP:0002843) | 1.72336100 |
| 167 | Glomerulonephritis (HP:0000099) | 1.72228181 |
| 168 | Nasal polyposis (HP:0100582) | 1.70844279 |
| 169 | Acne (HP:0001061) | 1.70369022 |
| 170 | Gastrointestinal stroma tumor (HP:0100723) | 1.70194910 |
| 171 | Widely patent fontanelles and sutures (HP:0004492) | 1.70030400 |
| 172 | Prolonged QT interval (HP:0001657) | 1.69507940 |
| 173 | Abnormality of T cell number (HP:0011839) | 1.69501318 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LATS1 | 5.16641531 |
| 2 | MST4 | 3.11870094 |
| 3 | TTN | 3.05628503 |
| 4 | EPHB1 | 2.77739436 |
| 5 | STK38L | 2.72479228 |
| 6 | LATS2 | 2.54519648 |
| 7 | LMTK2 | 2.52755821 |
| 8 | MAP4K1 | 2.36668170 |
| 9 | STK38 | 2.31852733 |
| 10 | KSR2 | 2.30850966 |
| 11 | DMPK | 2.11520238 |
| 12 | BLK | 2.11080513 |
| 13 | TYK2 | 2.03957875 |
| 14 | TRIB3 | 1.99821700 |
| 15 | ZAP70 | 1.94642750 |
| 16 | ERN1 | 1.82604477 |
| 17 | LRRK2 | 1.79312423 |
| 18 | FGFR4 | 1.78405009 |
| 19 | CDK12 | 1.77831098 |
| 20 | TAOK3 | 1.77324558 |
| 21 | PRKD3 | 1.72770856 |
| 22 | TBK1 | 1.70846367 |
| 23 | TGFBR2 | 1.67743341 |
| 24 | JAK1 | 1.67559436 |
| 25 | MYLK | 1.66006051 |
| 26 | MAPKAPK3 | 1.62677007 |
| 27 | PRPF4B | 1.58359759 |
| 28 | SYK | 1.56709855 |
| 29 | BCKDK | 1.53848292 |
| 30 | STK10 | 1.48030412 |
| 31 | IRAK3 | 1.47370000 |
| 32 | RIPK4 | 1.46323110 |
| 33 | PHKG2 | 1.46241462 |
| 34 | PHKG1 | 1.46241462 |
| 35 | EPHA3 | 1.45460038 |
| 36 | STK4 | 1.41657610 |
| 37 | MAP3K14 | 1.37962262 |
| 38 | TIE1 | 1.36916928 |
| 39 | RIPK1 | 1.35386481 |
| 40 | NLK | 1.32979529 |
| 41 | MAP3K11 | 1.32052456 |
| 42 | JAK2 | 1.30907847 |
| 43 | SMG1 | 1.27903677 |
| 44 | EPHA2 | 1.24476704 |
| 45 | MARK2 | 1.23679119 |
| 46 | MAP3K3 | 1.22059450 |
| 47 | JAK3 | 1.21066307 |
| 48 | PTK6 | 1.20815134 |
| 49 | EEF2K | 1.18709714 |
| 50 | SIK3 | 1.18400722 |
| 51 | FES | 1.16995960 |
| 52 | PRKD1 | 1.15785698 |
| 53 | MAP3K7 | 1.15299387 |
| 54 | ITK | 1.14829660 |
| 55 | PIM2 | 1.14519703 |
| 56 | TRPM7 | 1.14076164 |
| 57 | MATK | 1.12013910 |
| 58 | MAP3K6 | 1.11253329 |
| 59 | DYRK1B | 1.10984158 |
| 60 | BTK | 1.08666544 |
| 61 | MAP3K2 | 1.07406398 |
| 62 | IKBKE | 1.06773740 |
| 63 | ACVR1B | 1.06682318 |
| 64 | HCK | 1.05559370 |
| 65 | FGFR3 | 1.02797110 |
| 66 | MELK | 1.02482775 |
| 67 | PKN2 | 1.00755249 |
| 68 | IKBKB | 1.00181187 |
| 69 | MAP3K13 | 0.99960220 |
| 70 | MAP2K3 | 0.99114213 |
| 71 | PRKD2 | 0.98883021 |
| 72 | MST1R | 0.93320284 |
| 73 | TNK2 | 0.91977997 |
| 74 | PIK3CA | 0.90204625 |
| 75 | PIM1 | 0.87345020 |
| 76 | RPS6KL1 | 0.86778996 |
| 77 | RPS6KC1 | 0.86778996 |
| 78 | IRAK2 | 0.86024077 |
| 79 | NME1 | 0.85437399 |
| 80 | FER | 0.83881445 |
| 81 | SIK1 | 0.83581060 |
| 82 | RPS6KA6 | 0.83212754 |
| 83 | MAP3K1 | 0.81811477 |
| 84 | OBSCN | 0.80886000 |
| 85 | PTK2B | 0.80089302 |
| 86 | PKN1 | 0.80035445 |
| 87 | CDC42BPA | 0.79719506 |
| 88 | PRKAA2 | 0.79145053 |
| 89 | CDK6 | 0.76626508 |
| 90 | GRK6 | 0.76435723 |
| 91 | KIT | 0.74989215 |
| 92 | CSK | 0.74690206 |
| 93 | FGR | 0.73318767 |
| 94 | NEK9 | 0.71601795 |
| 95 | CHUK | 0.70895846 |
| 96 | ROCK1 | 0.69585284 |
| 97 | LCK | 0.69301428 |
| 98 | PDK3 | 0.68327510 |
| 99 | PDK4 | 0.68327510 |
| 100 | PDPK1 | 0.67531997 |
| 101 | BMX | 0.67297735 |
| 102 | TXK | 0.67013717 |
| 103 | MARK3 | 0.65361561 |
| 104 | GRK7 | 0.64889466 |
| 105 | YES1 | 0.63958425 |
| 106 | KDR | 0.63231279 |
| 107 | WNK4 | 0.62458279 |
| 108 | CLK1 | 0.61924285 |
| 109 | RPS6KA2 | 0.61702731 |
| 110 | PRKG2 | 0.61481960 |
| 111 | CAMK1D | 0.59996823 |
| 112 | IRAK4 | 0.59935423 |
| 113 | PDGFRB | 0.59909191 |
| 114 | SGK3 | 0.59665874 |
| 115 | MAPK12 | 0.58787842 |
| 116 | IRAK1 | 0.57691114 |
| 117 | CSF1R | 0.56096997 |
| 118 | ROCK2 | 0.56087634 |
| 119 | PDK1 | 0.55463629 |
| 120 | CAMK1G | 0.54810395 |
| 121 | MAP2K6 | 0.53534000 |
| 122 | SIK2 | 0.52559957 |
| 123 | WNK1 | 0.52483529 |
| 124 | MAP2K2 | 0.52395856 |
| 125 | STK11 | 0.51833997 |
| 126 | PRKCQ | 0.51355624 |
| 127 | MAP3K10 | 0.50795806 |
| 128 | TEC | 0.49717860 |
| 129 | RET | 0.49417479 |
| 130 | TAOK1 | 0.48824324 |
| 131 | RPS6KB2 | 0.48487697 |
| 132 | TESK2 | 0.48373459 |
| 133 | PTK2 | 0.47627993 |
| 134 | MAP2K1 | 0.45183750 |
| 135 | LYN | 0.44989848 |
| 136 | ICK | 0.44410096 |
| 137 | STK24 | 0.44225343 |
| 138 | MAP2K4 | 0.42875290 |
| 139 | PRKCZ | 0.38917628 |
| 140 | TESK1 | 0.37250091 |
| 141 | FYN | 0.32361483 |
| 142 | MAPK7 | 0.31879178 |
| 143 | PIK3CG | 0.31800980 |
| 144 | MAPKAPK2 | 0.31270851 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.68403326 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.12290478 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.10863681 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.03542059 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.90044874 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.85915139 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.82410413 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.79737343 |
| 9 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.70884389 |
| 10 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.65018076 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.63148970 |
| 12 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.61698275 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.60293736 |
| 14 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.57493512 |
| 15 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.57076970 |
| 16 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.55148239 |
| 17 | ABC transporters_Homo sapiens_hsa02010 | 1.48616065 |
| 18 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.40972035 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.39150989 |
| 20 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.38801655 |
| 21 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.36487307 |
| 22 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.35891565 |
| 23 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.34965738 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.34862844 |
| 25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.34697567 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.34607445 |
| 27 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.32217963 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.30754989 |
| 29 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.30374166 |
| 30 | Lysosome_Homo sapiens_hsa04142 | 1.30239092 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.29591842 |
| 32 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.28467639 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.25776533 |
| 34 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.22754238 |
| 35 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.22351296 |
| 36 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.21056949 |
| 37 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.18627350 |
| 38 | Insulin resistance_Homo sapiens_hsa04931 | 1.17921314 |
| 39 | Other glycan degradation_Homo sapiens_hsa00511 | 1.14983134 |
| 40 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11676876 |
| 41 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.11043377 |
| 42 | Pertussis_Homo sapiens_hsa05133 | 1.11006442 |
| 43 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.08973170 |
| 44 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.08901286 |
| 45 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.07980007 |
| 46 | Allograft rejection_Homo sapiens_hsa05330 | 1.07071595 |
| 47 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.06440934 |
| 48 | Endometrial cancer_Homo sapiens_hsa05213 | 1.06194464 |
| 49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.03740987 |
| 50 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.03603984 |
| 51 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.02079581 |
| 52 | Salmonella infection_Homo sapiens_hsa05132 | 1.01758699 |
| 53 | Platelet activation_Homo sapiens_hsa04611 | 1.01307488 |
| 54 | Measles_Homo sapiens_hsa05162 | 0.97303427 |
| 55 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.97150032 |
| 56 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.93551292 |
| 57 | Apoptosis_Homo sapiens_hsa04210 | 0.93314081 |
| 58 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.91996728 |
| 59 | Amoebiasis_Homo sapiens_hsa05146 | 0.91251599 |
| 60 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.89068242 |
| 61 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.88507021 |
| 62 | Phagosome_Homo sapiens_hsa04145 | 0.87434533 |
| 63 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.85498264 |
| 64 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.85193732 |
| 65 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.84538897 |
| 66 | Parkinsons disease_Homo sapiens_hsa05012 | 0.84059093 |
| 67 | Malaria_Homo sapiens_hsa05144 | 0.83524265 |
| 68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81728887 |
| 69 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.81569988 |
| 70 | Legionellosis_Homo sapiens_hsa05134 | 0.81272982 |
| 71 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.81020092 |
| 72 | Thyroid cancer_Homo sapiens_hsa05216 | 0.80956042 |
| 73 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.80272074 |
| 74 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.78844955 |
| 75 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.78735456 |
| 76 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.78476636 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.78161790 |
| 78 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.77901803 |
| 79 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.77462060 |
| 80 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.77328376 |
| 81 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.77089482 |
| 82 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.76655030 |
| 83 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.73992146 |
| 84 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.73808765 |
| 85 | Galactose metabolism_Homo sapiens_hsa00052 | 0.73360393 |
| 86 | Hepatitis B_Homo sapiens_hsa05161 | 0.73163926 |
| 87 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.72704927 |
| 88 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.72132895 |
| 89 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.71599818 |
| 90 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.70351164 |
| 91 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.69739554 |
| 92 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.68745925 |
| 93 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.68519318 |
| 94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.68394649 |
| 95 | Colorectal cancer_Homo sapiens_hsa05210 | 0.68086233 |
| 96 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.65875768 |
| 97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.65004815 |
| 98 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.64221352 |
| 99 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.64190200 |
| 100 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.63848447 |
| 101 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63540390 |
| 102 | Hepatitis C_Homo sapiens_hsa05160 | 0.63293713 |
| 103 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.62681122 |
| 104 | Adherens junction_Homo sapiens_hsa04520 | 0.62036793 |
| 105 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.60786076 |
| 106 | Mineral absorption_Homo sapiens_hsa04978 | 0.60248093 |
| 107 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.59335947 |
| 108 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.58947411 |
| 109 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58900361 |
| 110 | Alzheimers disease_Homo sapiens_hsa05010 | 0.58469375 |
| 111 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.57588182 |
| 112 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.57445847 |
| 113 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.57072157 |
| 114 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.56941254 |
| 115 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.56896803 |
| 116 | Peroxisome_Homo sapiens_hsa04146 | 0.56181796 |
| 117 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.56092964 |
| 118 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.55102400 |
| 119 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.54242872 |
| 120 | Influenza A_Homo sapiens_hsa05164 | 0.53264374 |
| 121 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.53054246 |
| 122 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.52438851 |
| 123 | Lysine degradation_Homo sapiens_hsa00310 | 0.51739267 |
| 124 | Bladder cancer_Homo sapiens_hsa05219 | 0.51286481 |
| 125 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.51218275 |
| 126 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.51133306 |
| 127 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.49542643 |
| 128 | Bile secretion_Homo sapiens_hsa04976 | 0.48568052 |
| 129 | Histidine metabolism_Homo sapiens_hsa00340 | 0.48119076 |
| 130 | Shigellosis_Homo sapiens_hsa05131 | 0.47901870 |
| 131 | Focal adhesion_Homo sapiens_hsa04510 | 0.47897800 |
| 132 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.47826013 |
| 133 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47600158 |
| 134 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46623962 |
| 135 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.45360312 |
| 136 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.44780634 |
| 137 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.43617738 |
| 138 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.43365186 |
| 139 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.42154042 |
| 140 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.42144380 |
| 141 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41690773 |

